This Article  • Full text  • PDF  • Correction  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (49)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in this journal  Topic Collections  • Aging/ Geriatrics  • Cataracts/ Lens  • Randomized Controlled Trial  • Alert me on articles by topic  Social Bookmarking   What's this?

AREDS Report No. 9

Age-Related Eye Disease Study Research Group

Arch Ophthalmol. 2001;119:1439-1452.

Background  Experimental and observational data suggest that micronutrients with antioxidant capabilities may retard the development of age-related cataract.

Objective  To evaluate the effect of a high-dose antioxidant formulation on the development and progression of age-related lens opacities and visual acuity loss.

Design  The 11-center Age-Related Eye Disease Study (AREDS) was a double-masked clinical trial. Participants were randomly assigned to receive daily oral tablets containing either antioxidants (vitamin C, 500 mg; vitamin E, 400 IU; and beta carotene, 15 mg) or no antioxidants. Participants with more than a few small drusen were also randomly assigned to receive tablets with or without zinc (80 mg of zinc as zinc oxide) and copper (2 mg of copper as cupric oxide) as part of the age-related macular degeneration trial. Baseline and annual (starting at year 2) lens photographs were graded at a reading center for the severity of lens opacities using the AREDS cataract grading scale.

Main Outcome Measures  Primary outcomes were (1) an increase from baseline in nuclear, cortical, or posterior subcapsular opacity grades or cataract surgery, and (2) at least moderate visual acuity loss from baseline (15 letters). Primary analyses used repeated-measures logistic regression with a statistical significance level of P = .01. Serum level measurements, medical histories, and mortality rates were used for safety monitoring.

Results  Of 4757 participants enrolled, 4629 who were aged from 55 to 80 years had at least 1 natural lens present and were followed up for an average of 6.3 years. No statistically significant effect of the antioxidant formulation was seen on the development or progression of age-related lens opacities (odds ratio = 0.97, P = .55). There was also no statistically significant effect of treatment in reducing the risk of progression for any of the 3 lens opacity types or for cataract surgery. For the 1117 participants with no age-related macular degeneration at baseline, no statistically significant difference was noted between treatment groups for at least moderate visual acuity loss. No statistically significant serious adverse effect was associated with treatment.

Conclusion  Use of a high-dose formulation of vitamin C, vitamin E, and beta carotene in a relatively well-nourished older adult cohort had no apparent effect on the 7-year risk of development or progression of age-related lens opacities or visual acuity loss.

The AREDS investigators have no commercial or proprietary interest in the supplements used in this study.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLES

Antioxidants and Zinc to Prevent Progression of Age-Related Macular Degeneration
Lee M. Jampol and Frederick L. Ferris, III
JAMA. 2001;286(19):2466-2468.
EXTRACT | FULL TEXT  

A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation With Vitamins C and E, Beta Carotene, and Zinc for Age-Related Macular Degeneration and Vision Loss: AREDS Report No. 8
Age-Related Eye Disease Study Research Group
Arch Ophthalmol. 2001;119(10):1417-1436.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Screening Older Adults for Impaired Visual Acuity: A Review of the Evidence for the U.S. Preventive Services Task Force
Chou et al.
ANN INTERN MED 2009;151:44-58.
ABSTRACT | FULL TEXT  

Micronutrients and Older Adults
Marian and Sacks
Nutr Clin Pract 2009;24:179-195.
ABSTRACT | FULL TEXT  

Coenzyme Q10 in the Human Retina
Qu et al.
IOVS 2009;50:1814-1818.
ABSTRACT | FULL TEXT  

The Gel State of the Vitreous and Ascorbate-Dependent Oxygen Consumption: Relationship to the Etiology of Nuclear Cataracts
Shui et al.
Arch Ophthalmol 2009;127:475-482.
ABSTRACT | FULL TEXT  

Bayesian model averaging in meta-analysis: vitamin E supplementation and mortality
Berry et al.
Clin Trials 2009;6:28-41.
ABSTRACT  

Blood Levels of Vitamin C, Carotenoids and Retinol Are Inversely Associated with Cataract in a North Indian Population
Dherani et al.
IOVS 2008;49:3328-3335.
ABSTRACT | FULL TEXT  

Retinal Dysfunction and Progressive Retinal Cell Death in SOD1-Deficient Mice
Hashizume et al.
Am. J. Pathol. 2008;172:1325-1331.
ABSTRACT | FULL TEXT  

Characterization of a Bcl-XL-Interacting Protein FKBP8 and Its Splice Variant in Human RPE Cells
Chen et al.
IOVS 2008;49:1721-1727.
ABSTRACT | FULL TEXT  

The Role of Selenium in Chronic Disease
Boosalis
Nutr Clin Pract 2008;23:152-160.
ABSTRACT | FULL TEXT  

What can patients expect from cataract surgery?
BOLLINGER and LANGSTON
Cleveland Clinic Journal of Medicine 2008;75:193-200.
ABSTRACT | FULL TEXT  

Dietary Carotenoids, Vitamins C and E, and Risk of Cataract in Women: A Prospective Study
Christen et al.
Arch Ophthalmol 2008;126:102-109.
ABSTRACT | FULL TEXT  

Genetic susceptibility to age-related macular degeneration: a paradigm for dissecting complex disease traits
Swaroop et al.
Hum Mol Genet 2007;16:R174-R182.
ABSTRACT | FULL TEXT  

Nuclear Cataract: Do Statins Reduce Risk?
Leske
Arch Ophthalmol 2007;125:401-402.
FULL TEXT  

Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary Prevention: Systematic Review and Meta-analysis
Bjelakovic et al.
JAMA 2007;297:842-857.
ABSTRACT | FULL TEXT  

National Institutes of Health State-of-the-Science Conference Statement: Multivitamin/Mineral Supplements and Chronic Disease Prevention
NIH State-of-the Science Panel
Am. J. Clin. Nutr. 2007;85:257S-264S.
FULL TEXT  

The Efficacy and Safety of Multivitamin and Mineral Supplement Use To Prevent Cancer and Chronic Disease in Adults: A Systematic Review for a National Institutes of Health State-of-the-Science Conference
Huang et al.
ANN INTERN MED 2006;145:372-385.
ABSTRACT | FULL TEXT  

National Institutes of Health State-of-the-Science Conference Statement: Multivitamin/Mineral Supplements and Chronic Disease Prevention
NIH State-of-the-Science Panel*
ANN INTERN MED 2006;145:364-371.
FULL TEXT  

Micronutrients in health and disease.
Shenkin
Postgrad. Med. J. 2006;82:559-567.
ABSTRACT | FULL TEXT  

Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: A model of age-related macular degeneration
Imamura et al.
Proc. Natl. Acad. Sci. USA 2006;103:11282-11287.
ABSTRACT | FULL TEXT  

The Antioxidants in Prevention of Cataracts Study: effects of antioxidant supplements on cataract progression in South India
Gritz et al.
Br J Ophthalmol 2006;90:847-851.
ABSTRACT | FULL TEXT  

Statin Use and Incident Nuclear Cataract
Klein et al.
JAMA 2006;295:2752-2758.
ABSTRACT | FULL TEXT  

The effect of undernutrition in the development of frailty in older persons.
Bischoff et al.
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2006;61:585-589.
FULL TEXT  

Development of Cataract and Associated Risk Factors: The Visual Impairment Project
Mukesh et al.
Arch Ophthalmol 2006;124:79-85.
ABSTRACT | FULL TEXT  

The Age-Related Eye Disease Study Severity Scale for Age-Related Macular Degeneration: AREDS Report No. 17
Age-Related Eye Disease Study Research Group
Arch Ophthalmol 2005;123:1484-1498.
ABSTRACT | FULL TEXT  

Age-Related Eye Disease Study Severity Scale and Simplified Severity Scale for Age-Related Macular Degeneration
Mitchell and Foran
Arch Ophthalmol 2005;123:1598-1599.
FULL TEXT  

Plasma 8-Isoprostane Concentrations in Patients with Age-Related Cataracts
Wang et al.
Clin. Chem. 2005;51:1541-1544.
FULL TEXT  

Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer: The Women's Health Study: A Randomized Controlled Trial
Lee et al.
JAMA 2005;294:56-65.
ABSTRACT | FULL TEXT  

Effects of Long-term Vitamin E Supplementation on Cardiovascular Events and Cancer: A Randomized Controlled Trial
The HOPE and HOPE-TOO Trial Investigators
JAMA 2005;293:1338-1347.
ABSTRACT | FULL TEXT  

Oxidant-Induced Apoptosis in Human Retinal Pigment Epithelial Cells: Dependence on Extracellular Redox State
Jiang et al.
IOVS 2005;46:1054-1061.
ABSTRACT | FULL TEXT  

Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality
Miller et al.
ANN INTERN MED 2005;142:37-46.
ABSTRACT | FULL TEXT  

Vitamin E Supplements: Good in Theory, but Is the Theory Good?
Greenberg
ANN INTERN MED 2005;142:75-76.
FULL TEXT  

Scanning Laser Entoptic Perimetry for the Detection of Age-Related Macular Degeneration
Freeman et al.
Arch Ophthalmol 2004;122:1647-1651.
ABSTRACT | FULL TEXT  

Oxidative Stress Plays an Important Role in the Pathogenesis of Drug-Induced Retinopathy
Toler
Exp. Biol. Med. 2004;229:607-615.
ABSTRACT | FULL TEXT  

Hormones and Supplements: Do They Work?: Micronutrient Supplementation in Later Life: Limited Evidence for Benefit
Dangour et al.
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2004;59:B659-B673.
ABSTRACT | FULL TEXT  

Increased Expression of Iron-Regulating Genes in Monkey and Human Glaucoma
Farkas et al.
IOVS 2004;45:1410-1417.
ABSTRACT | FULL TEXT  

Doctor, What Vitamins Should I Take for My Eyes?
Mares et al.
Arch Ophthalmol 2004;122:628-635.
FULL TEXT  

Basal Laminar Deposit Formation in APO B100 Transgenic Mice: Complex Interactions between Dietary Fat, Blue Light, and Vitamin E
Espinosa-Heidmann et al.
IOVS 2004;45:260-266.
ABSTRACT | FULL TEXT  

Important Causes of Visual Impairment in the World Today
Congdon et al.
JAMA 2003;290:2057-2060.
FULL TEXT  

Relationship between Refraction and Prevalent as well as Incident Age-Related Maculopathy: The Rotterdam Study
Ikram et al.
IOVS 2003;44:3778-3782.
ABSTRACT | FULL TEXT  

Routine Vitamin Supplementation To Prevent Cancer and Cardiovascular Disease: Recommendations and Rationale
U.S. Preventive Services Task Force*
ANN INTERN MED 2003;139:51-55.
ABSTRACT | FULL TEXT  

Routine Vitamin Supplementation To Prevent Cardiovascular Disease: A Summary of the Evidence for the U.S. Preventive Services Task Force
Morris and Carson
ANN INTERN MED 2003;139:56-70.
ABSTRACT | FULL TEXT  

A Randomized Trial of Beta Carotene and Age-Related Cataract in US Physicians
Christen et al.
Arch Ophthalmol 2003;121:372-378.
ABSTRACT | FULL TEXT  

Vitamin C as an Antioxidant: Evaluation of Its Role in Disease Prevention
Padayatty et al.
J. Am. Coll. Nutr. 2003;22:18-35.
ABSTRACT | FULL TEXT  

National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS): AREDS Report No. 10
Clemons et al.
Arch Ophthalmol 2003;121:211-217.
ABSTRACT | FULL TEXT  

Lens Aging in Relation to Nutritional Determinants and Possible Risk Factors for Age-Related Cataract
Berendschot et al.
Arch Ophthalmol 2002;120:1732-1737.
ABSTRACT | FULL TEXT  

Vitamin E supplementation and macular degeneration: randomised controlled trial
Taylor et al.
BMJ 2002;325:11-11.
ABSTRACT | FULL TEXT  

Vitamin C Is Associated with Reduced Risk of Cataract in a Mediterranean Population
Valero et al.
J. Nutr. 2002;132:1299-1306.
ABSTRACT | FULL TEXT  

The Effect of Five-Year Zinc Supplementation on Serum Zinc, Serum Cholesterol and Hematocrit in Persons Randomly Assigned to Treatment Group in the Age-Related Eye Disease Study: AREDS Report No. 7
The Age-Related Eye Disease Study Research Group
J. Nutr. 2002;132:697-702.
ABSTRACT | FULL TEXT  

Antioxidants and Zinc to Prevent Progression of Age-Related Macular Degeneration
Jampol and Ferris
JAMA 2001;286:2466-2468.
FULL TEXT  

Antioxidants and Zinc for Age-Related Eye Diseases
JWatch General 2001;2001:2-2.
FULL TEXT  

A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation With Vitamins C and E, Beta Carotene, and Zinc for Age-Related Macular Degeneration and Vision Loss: AREDS Report No. 8
Age-Related Eye Disease Study Research Group
Arch Ophthalmol 2001;119:1417-1436.
ABSTRACT | FULL TEXT